URGENT AND IMPORTANT ANNOUNCEMENT ON PBP WORLD MEETING
Due to the ongoing spread of Corona (SARS-CoV-2) virus over Europe and a changed recommendation from the Austria Center Vienna, we regret to announce that the 12th PBP World Meeting is postponed into the year 2021. The organizers of the conference are proud that over 1.100 participants and exhibitors were so confident maintaining their registrations until today. However, we feel highly responsible for the health of our speakers, visitors and public in general. We sincerely regret any inconveniences this decision may cause. We will circulate all information on new dates in Vienna, invited and accepted presentations, registrations and conditions within the next few days.
Dear participant / exhibitor of the 12th PBP World Meeting,
As we have announced by an alerting message yesterday, the 12th PBP World Meeting in Vienna, which was initially to be held on 23-26 March 2020, will be postponed to 7-11 February 2021.
The organizers would like to express their explicit regrets for any inconveniences this may cause.
As the warning signals were elevated for a visit of Vienna, and since various countries, universities and companies have filed travel bans or instructions for quarantine upon return, we came to the conclusion that the character of a “World Meeting” would be lost under the given, exceptional circumstances. In the sake of our participants, exhibitors, speakers as well as of their families and friends, we felt liable to enable a safe visit of our conference which became virtually impossible.
For these reasons, we decided to postpone the 12th PBP World Meeting and the ResearchPharm® exhibition to 07th to 11th of February, 2021, keeping the beautiful location Vienna.
Registrations remain valid for the new event dates. No actions are needed from your side.
Please note that the name related to a registration may be changed without fee.
In case your participation at the new meeting dates might not be possible, your registration fee will be reimbursed. In this case, please send a short message to firstname.lastname@example.org. You will then receive further information on the refunding process.
Poster presentations and short talks:
Accepted poster presentations and short talks remain valid and will be rescheduled to the new meeting dates. No actions are needed from your side.
If you have to withdraw your poster presentation or short talk, please send a short message to email@example.com.
It will be possible to submit additional new abstracts for poster presentations and short talks (there is no need to re-submit already accepted abstracts). Further information about the deadline and procedure will be announced in the coming weeks.
We do hope that you may understand our decision and that you will support our PBP World Meeting in 2021.
The PBP Organizers
Robert Langer Laureate of the Maurice Marie-Janot Award 2020
Professor Robert Langer at the Massachusetts Institute of Technology receives the “2020 Maurice Marie-Janot Award”. This price recognizes an individual researcher, whose pioneering work has a groundbreaking impact in the fields of Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology. The Jury is composed of 70 scientists from all over the world, who are known for their relevant contributions to the Pharmaceutical Sciences.
Robert Langer is one of 12 Institute Professors at the Massachusetts Institute of Technology (MIT); being an Institute Professor is the highest honor that can be awarded to a faculty member. He has written nearly 1,500 articles, which have been cited over 300,000 times; his h-index of 272 is the highest of any engineer in history. He has more than 1,350 issued and pending patents worldwide. His patents have been licensed or sublicensed to over 400 companies. He served as Chairman of the FDA’s Science Board (its highest advisory board) from 1999-2002. His over 220 awards include both the United States National Medal of Science and the United States National Medal of Technology and Innovation (he is one of 4 living individuals to have received both these honors), the Charles Stark Draper Prize (often called the Engineering Nobel Prize), Albany Medical Center Prize, Breakthrough Prize in Life Sciences, Kyoto Prize, Wolf Prize for Chemistry, Millennium Technology Prize, Priestley Medal (highest award of the American Chemical Society), Gairdner Prize, Dreyfus Prize in Chemical Sciences, Maurice Marie-Janot Award, and the Lemelson-MIT prize, for being “one of history’s most prolific inventors in medicine.” He holds 34 honorary doctorates and has been elected to the National Academy of Medicine, the National Academy of Engineering, the National Academy of Sciences and the National Academy of Inventors.
The Maurice Marie Janot Award is granted by APGI and sponsored by
12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
Vienna, 23-26 March, 2020
Two parallel sessions will be dedicated to industry related topics with invited speakers from all over the world.
In addition, two parallel sessions will address all the other topics with short lectures selected from submitted abstracts.
More information will follow closer to the meeting!
Offre de stage de 6 mois à partir de Février 2020
Pour postuler, envoyez votre CV et votre lettre de motivation à firstname.lastname@example.org
Young investigator award
APGI thesis award 2018/2019
Faculty of Pharmaceutical Sciences, Ghent University
Promotors: Prof. Katrien Remaut and Prof. Stefaan De Smedt
Titre: What you seen is what you get: The physicochemistry of nanoparticles dictates how they cross ocular delivery barriers and alter autophagy